Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?

BACKGROUND: Neoadjuvant immunotherapy combined with chemotherapy has been used to treat locally advanced non–small cell lung cancer (NSCLC). Several systems have been developed for response evaluation. The aim of this study was to evaluate the predictive value of response evaluation criteria in soli...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuan, Ma, Dongjie, Qin, Yingzhi, Li, Shanqing, Li, Ji, Jiang, Ying, Wang, Mengzhao, Xu, Yan, Zhao, Jing, Chen, Minjiang, Cheng, Wuying, Hu, Ke, Liu, Hongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260491/
https://www.ncbi.nlm.nih.gov/pubmed/37094918
http://dx.doi.org/10.1111/1759-7714.14909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260491/
https://www.ncbi.nlm.nih.gov/pubmed/37094918
http://dx.doi.org/10.1111/1759-7714.14909

Ejemplares similares